scholarly journals Covalently tethered transforming growth factor beta in PEG hydrogels promotes chondrogenic differentiation of encapsulated human mesenchymal stem cells

2012 ◽  
Vol 2 (5) ◽  
pp. 305-312 ◽  
Author(s):  
Joshua D. McCall ◽  
Jacob E. Luoma ◽  
Kristi S. Anseth
2010 ◽  
Vol 16 (2) ◽  
pp. 453-464 ◽  
Author(s):  
Andrea Dickhut ◽  
Verena Dexheimer ◽  
Katja Martin ◽  
Rebekka Lauinger ◽  
Christian Heisel ◽  
...  

2018 ◽  
Vol 26 ◽  
pp. S38-S39
Author(s):  
M. Ruiz ◽  
K. Toupet ◽  
G. Fonteneau ◽  
M. Maumus ◽  
C. Jorgensen ◽  
...  

2020 ◽  
Vol 21 (6) ◽  
pp. 1967 ◽  
Author(s):  
Jae-Sung Ryu ◽  
Sang Young Seo ◽  
Eun-Jeong Jeong ◽  
Jong-Yeup Kim ◽  
Yong-Gon Koh ◽  
...  

Mesenchymal stem cells, also known as multipotent stromal progenitor cells, can differentiate into cells of mesodermal lineage. Gangliosides are sialic acid-conjugated glycosphingolipids that are believed to regulate cell differentiation and several signaling molecules. These molecules are localized in glycosphingolipid-enriched microdomains on the cell surface and are regulated by glycosphingolipid composition. Transforming growth factor-beta (TGF-β) signaling plays a critical role in chondrogenic differentiation. However, the role of gangliosides in chondrogenesis is not understood. In this study, the relationship between the ganglioside GM3 and TGF-β activation, during chondrogenic differentiation, was investigated using an aggregate culture of human synovial membrane-derived mesenchymal stem cells. We showed that the gangliosides GM3 and GD3 were expressed after the chondrogenic differentiation of hSMSC aggregates. To test whether GM3 affected the chondrogenic differentiation of hSMSC aggregates, we used GM3 treatment during chondrogenic differentiation. The results showed that the group treated with 5 μM GM3 had higher expression of chondrogenic specific markers, increased toluidine blue, and safranin O staining, and increased accumulation of glycosaminoglycans compared with the untreated group. Furthermore, GM3 treatment enhanced TGF-β signaling via SMAD 2/3 during the chondrogenic differentiation of hSMSC aggregates. Taken together, our results suggested that GM3 may be useful in developing therapeutic agents for cell-based articular cartilage regeneration in articular cartilage disease.


Sign in / Sign up

Export Citation Format

Share Document